A carregar...

Orphan Therapies: Making Best Use of Postmarket Data

BACKGROUND: Postmarket surveillance of the comparative safety and efficacy of orphan therapeutics is challenging, particularly when multiple therapeutics are licensed for the same orphan indication. To make best use of product-specific registry data collected to fulfill regulatory requirements, we p...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Maro, Judith C., Brown, Jeffrey S., Pan, Gerald J. Dal, Li, Lingling
Formato: Artigo
Idioma:Inglês
Publicado em: Springer US 2014
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4124121/
https://ncbi.nlm.nih.gov/pubmed/25029972
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11606-014-2882-1
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!